Abstract
A retrospective analysis of ovarian cancer patients registered with the West Midlands Cancer Registry from 1 January 1985 to 31 December 1987 was undertaken to examine the variables associated with survival patterns, with particular reference to the specialty of the surgeon. A total of 1,654 patients were registered, of whom 1,184 had histologically confirmed ovarian cancer, with the operator identified. This consisted of 870 patients operated on by gynaecologists and 314 operated on by general surgeons. A significantly older population and a greater number of patients with stage III/IV disease were operated on by general surgeons. The median survival of patients under the general surgeons' care was 9.87 months, significantly lower (P < 0.0001) than the survival of the gynaecologists' patients (median survival = 29.1 months). Univariate and multivariate analysis correlated poor prognosis with advanced stage disease, older age, the presence of bulky residual tumour and a general surgeon as the operator. Stepwise Cox's proportional hazard analysis confirmed the general surgeon as an independent adverse prognostic factor with a relative hazard ratio of 1.34 (95% confidence interval = 1.05-1.71). Accepting the limitations of retrospective reviews, these findings suggest that every attempt be made to ensure that a gynaecologist is involved in the treatment of patients with ovarian pathology.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alberts D. S., Dahlberg S., Green S. J., Garcia D., Hannigan E. V., O'Toole R., Stock-Novack D., Surwit E. A., Malviya V. K., Jolles C. J. Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group study. Cancer. 1993 Jan 15;71(2 Suppl):618–627. doi: 10.1002/cncr.2820710220. [DOI] [PubMed] [Google Scholar]
- Eisenkop S. M., Spirtos N. M., Montag T. W., Nalick R. H., Wang H. J. The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol. 1992 Nov;47(2):203–209. doi: 10.1016/0090-8258(92)90107-t. [DOI] [PubMed] [Google Scholar]
- Gulliford M. C., Petruckevitch A., Burney P. G. Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment. BMJ. 1991 Aug 24;303(6800):437–440. doi: 10.1136/bmj.303.6800.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lund B., Williamson P. Prognostic factors for overall survival in patients with advanced ovarian carcinoma. Ann Oncol. 1991 Apr;2(4):281–287. doi: 10.1093/oxfordjournals.annonc.a057937. [DOI] [PubMed] [Google Scholar]
- Marchetti D. L., Lele S. B., Priore R. L., McPhee M. E., Hreshchyshyn M. M. Treatment of advanced ovarian carcinoma in the elderly. Gynecol Oncol. 1993 Apr;49(1):86–91. doi: 10.1006/gyno.1993.1091. [DOI] [PubMed] [Google Scholar]
- Matthews H. R., Powell D. J., McConkey C. C. Effect of surgical experience on the results of resection for oesophageal carcinoma. Br J Surg. 1986 Aug;73(8):621–623. doi: 10.1002/bjs.1800730811. [DOI] [PubMed] [Google Scholar]
- Mayer A. R., Chambers S. K., Graves E., Holm C., Tseng P. C., Nelson B. E., Schwartz P. E. Ovarian cancer staging: does it require a gynecologic oncologist? Gynecol Oncol. 1992 Nov;47(2):223–227. doi: 10.1016/0090-8258(92)90110-5. [DOI] [PubMed] [Google Scholar]
- Nguyen H. N., Averette H. E., Hoskins W., Penalver M., Sevin B. U., Steren A. National survey of ovarian carcinoma. Part V. The impact of physician's specialty on patients' survival. Cancer. 1993 Dec 15;72(12):3663–3670. doi: 10.1002/1097-0142(19931215)72:12<3663::aid-cncr2820721218>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
- Timm J. Ovarian carcinoma--a 10-year series from a provincial hospital. Acta Obstet Gynecol Scand. 1973;52(2):103–108. doi: 10.3109/00016347309158297. [DOI] [PubMed] [Google Scholar]